↓ Skip to main content

Dove Medical Press

Research Status and Outlook of PD-1/PD-L1 Inhibitors for Cancer Therapy

Overview of attention for article published in Drug Design, Development and Therapy, September 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#43 of 2,284)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
7 news outlets
twitter
2 X users

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
175 Mendeley
Title
Research Status and Outlook of PD-1/PD-L1 Inhibitors for Cancer Therapy
Published in
Drug Design, Development and Therapy, September 2020
DOI 10.2147/dddt.s267433
Pubmed ID
Authors

Leilei Ai, Jian Chen, Hao Yan, Qiaojun He, Peihua Luo, Zhifei Xu, Xiaochun Yang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 175 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 11%
Student > Master 19 11%
Student > Ph. D. Student 18 10%
Researcher 13 7%
Student > Doctoral Student 6 3%
Other 18 10%
Unknown 82 47%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 28 16%
Medicine and Dentistry 18 10%
Pharmacology, Toxicology and Pharmaceutical Science 11 6%
Agricultural and Biological Sciences 7 4%
Unspecified 6 3%
Other 20 11%
Unknown 85 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 52. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2024.
All research outputs
#824,486
of 25,838,141 outputs
Outputs from Drug Design, Development and Therapy
#43
of 2,284 outputs
Outputs of similar age
#23,556
of 426,892 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 40 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,892 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.